“Potential role of interleukin 28B-gene polymorphism and natural immune enhancer treatment response in chronic HCV patients” (2015) Journal of Biochemistry, Microbiology and Biotechnology, 3(1), pp. 15–20. doi:10.54987/jobimb.v3i1.230.